Trial Profile
Atomoxetine, Placebo, and Parent Training in Autism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jan 2019
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- 01 Oct 2016 Results (n=117) from a 24 week extension of this study, published in the Journal of the American Academy of Child and Adolescent Psychiatry
- 03 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.